Promac Pharma Llp - Due diligence report

A 360° intelligence report on Promac Pharma Llp: trust score, financial health, credit view, compliance, directors, growth and distress sign…

2022-08-18 South West Delhi, Delhi Active
Connect MCP
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Promac Pharma Llp — 360° Intelligence Report

Generated from MCA filings & public records
84/100
Trust Score
Low Risk

Promac Pharma Llp is assessed as Low Risk with a Trust Score of 84/100. Promac Pharma Llp is an active limited liability partnership incorporated in 2022, operating in the Business Services sector. Processed financial statements are not yet available for trend analysis. Based on MCA filings and public records, it currently shows a low compliance risk and an unassessed financial risk profile.

Report generated on 18 Oct 2026 from the latest processed filings. Promac Pharma Llp snapshot & full profile →

Financial Health › No Data
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
84/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
88/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreNo Data
N/A
No processed financial statements available yet.
Credit Risk ScoreNo Data
N/A
Financial statements needed for a credit view.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreNo Data
N/A
Needs at least two filed years to measure growth.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

No processed financials
Financial statements are not yet processed for this company. Trend analysis will appear once filings are available.
04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: N/A No Data
  • Financial statements needed for a credit view.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 88/100 Low Risk
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2025).
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
UDITA AGARWAL 01234567 Director 01/04/2018 6 yrs Approved
SHALU SHARMA 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
06

Ownership & Group Intelligence

Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth N/A · Distress 90
Growth signals & trust indicators
Young company (4 years).
Financials unavailable - score leans on compliance and governance signals.
Distress signals & risk flags
No critical warning flags detected in the available data.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence87/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • No distress signals on file.
  • No financials on record - ask for audited statements.
Banker assessment77/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • No filed financials - rely on banking statements and GST data.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view64/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Request management accounts - public filings insufficient.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 5 events
31 Mar 2025
Last AGM held
Annual general meeting
Latest balance sheet
Filed with ROC
18 Aug 2022
Incorporated
Registered with Roc Delhi
Director appointed
UDITA AGARWAL (Designated Partner)
Director appointed
SHALU SHARMA (Designated Partner)
10

Key Observations

Auto-generated from the data above
Compliance record is strong - status, filings and flags are clean.
2 active director(s) / partner(s); board looks stable and experienced.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Niuleer Contrabuild Development Private Limited U45309DL2018PTC334477 Delhi
Surescan India Private Limited U46593DL2023FTC411129 Delhi
Goldaxe Realcon Private Limited U68200DL2023PTC423065 Delhi
Apport Constructions Private Limited U45200DL2008PTC184812 Delhi
J P Overseas Private Limited U74899DL1994PTC059744 Delhi
Sattvam Tea Private Limited U47211DL2023PTC413686 Delhi
Vaibhav Farms Private Limited U74899DL1993PTC051658 Delhi
Tiysol Corporation Private Limited U72900DL2017PTC319804 Delhi
Tismastu Interior Decorator & Consulting Services Private Limited U74140DL2015PTC277675 Delhi
Fly Express Marketing Private Limited U63040DL2016PTC304281 Delhi
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Promac Pharma Llp before audits and certifications: compliance score 88/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Promac Pharma Llp: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score pending financials, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score n/a, margin trends, ownership structure and peer set for Promac Pharma Llp - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 84/100, distress signals and MSME payment-delay disclosures - know whether Promac Pharma Llp pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Promac Pharma Llp - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Promac Pharma Llp an active company?

Promac Pharma Llp has MCA status “Active” with a compliance score of 88/100 (Low Risk).

Is Promac Pharma Llp financially healthy?

Processed financial statements are not yet available for Promac Pharma Llp, so its financial health is unassessed.

Should I do business with Promac Pharma Llp?

Its overall Trust Score is 84/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Promac Pharma Llp?

See the directors and ownership sections above for board and shareholding detail. 2 active director(s) are on record.

Does Promac Pharma Llp have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Promac Pharma Llp up to date with its ROC filings?

Balance sheet slightly behind (Mar 2025). Overall compliance score: 88/100 (Low Risk).

Is it risky to lend to Promac Pharma Llp?

Filed financial statements are needed for a credit view - ask the company for audited statements and bank statements.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.